CTI BioPharma Corp. (NASDAQ: CTIC) Starts Presentation at 29th Annual ROTH Conference
CTI BioPharma (NASDAQ: CTIC) is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers. The company has a commercial presence in Europe with respect to PIXUVRI® and a late-stage development pipeline, including pacritinib for the treatment of patients … Continue reading “CTI BioPharma Corp. (NASDAQ: CTIC) Starts Presentation at 29th Annual ROTH Conference”
